Just a sample of the Echomail archive
Cooperative anarchy at its finest, still active today. Darkrealms is the Zone 1 Hub.
|    EARTH    |    Uhh, that 3rd rock from the sun?    |    8,931 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 8,765 of 8,931    |
|    ScienceDaily to All    |
|    Eliminating extra chromosomes in cancer     |
|    06 Jul 23 22:30:34    |
      MSGID: 1:317/3 64a79523       PID: hpt/lnx 1.9.0-cur 2019-01-08       TID: hpt/lnx 1.9.0-cur 2019-01-08        Eliminating extra chromosomes in cancer cells prevent tumor growth                      Date:        July 6, 2023        Source:        Yale University        Summary:        Cancer cells with extra chromosomes depend on those chromosomes for        tumor growth, a new study reveals, and eliminating them prevents        the cells from forming tumors. The findings, said the researchers,        suggest that selectively targeting extra chromosomes may offer a        new route for treating cancer.                      Facebook Twitter Pinterest LinkedIN Email              ==========================================================================       FULL STORY       ==========================================================================       Cancer cells with extra chromosomes depend on those chromosomes for       tumor growth, a new Yale study reveals, and eliminating them prevents       the cells from forming tumors. The findings, said the researchers,       suggest that selectively targeting extra chromosomes may offer a new       route for treating cancer.              The study was published July 6 in the journal Science.              Human cells typically have 23 pairs of chromosomes; extra chromosomes       are an anomaly known as aneuploidy.              "If you look at normal skin or normal lung tissue, for example, 99.9%       of the cells will have the right number of chromosomes," said Jason       Sheltzer, assistant professor of surgery at Yale School of Medicine and       senior author of the study. "But we've known for over 100 years that       nearly all cancers are aneuploid." However, it was unclear what role       extra chromosomes played in cancer -- for instance, whether they cause       cancer or are caused by it.              "For a long time, we could observe aneuploidy but not manipulate it. We       just didn't have the right tools," said Sheltzer, who is also a researcher       at Yale Cancer Center. "But in this study, we used the gene-engineering       technique CRISPR to develop a new approach to eliminate entire chromosomes       from cancer cells, which is an important technical advance. Being able       to manipulate aneuploid chromosomes in this way will lead to a greater       understanding of how they function." The study was co-led by former       lab members Vishruth Girish, now an M.D.-Ph.D.              student at Johns Hopkins School of Medicine, and Asad Lakhani, now a       postdoctoral researcher at Cold Spring Harbor Laboratory.              Using their newly developed approach -- which they dubbed Restoring       Disomy in Aneuploid cells using CRISPR Targeting, or ReDACT -- the       researchers targeted aneuploidy in melanoma, gastric cancer, and ovarian       cell lines. Specifically, they removed an aberrant third copy of the       long portion -- also known as the "q arm" -- of chromosome 1, which       is found in several types of cancer, is linked to disease progression,       and occurs early in cancer development.              "When we eliminated aneuploidy from the genomes of these cancer cells,       it compromised the malignant potential of those cells and they lost       their ability to form tumors," said Sheltzer.              Based on this finding, the researchers proposed cancer cells may have       an "aneuploidy addiction" -- a name referencing earlier research that       discovered that eliminating oncogenes, which can turn a cell into a cancer       cell, disrupts cancers' tumor-forming abilities. This finding led to a       model of cancer growth called "oncogene addiction." When investigating       how an extra copy of chromosome 1q might promote cancer, the researchers       found that multiple genes stimulated cancer cell growth when they were       overrepresented -- because they were encoded on three chromosomes instead       of the typical two.              This overexpression of certain genes also pointed the researchers to a       vulnerability that might be exploited to target cancers with aneuploidy.              Previous research has shown that a gene encoded on chromosome 1, known as       UCK2, is required to activate certain drugs. In the new study, Sheltzer       and his colleagues found that cells with an extra copy of chromosome 1       were more sensitive to those drugs than were cells with just two copies,       because of the overexpression of UCK2.              Further, they observed that this sensitivity meant that the drugs could       redirect cellular evolution away from aneuploidy, allowing for a cell       population with normal chromosome numbers and, therefore, less potential       to become cancerous. When researchers created a mixture with 20% aneuploid       cells and 80% normal cells, aneuploid cells took over: after nine days,       they made up 75% of the mixture. But when the researchers exposed the       20% aneuploid mixture to one of the UCK2-dependent drugs, the aneuploid       cells comprised just 4% of the mix nine days later.              "This told us that aneuploidy can potentially function as a therapeutic       target for cancer," said Sheltzer. "Almost all cancers are aneuploid,       so if you have some way of selectively targeting those aneuploid cells,       that could, theoretically, be a good way to target cancer while having       minimal effect on normal, non-cancerous tissue." More research needs       to be done before this approach can be tested in a clinical trial. But       Sheltzer aims to move this work into animal models, evaluate additional       drugs and other aneuploidies, and team up with pharmaceutical companies       to advance toward clinical trials.              "We're very interested in clinical translation," said Sheltzer. "So we're       thinking about how to expand our discoveries in a therapeutic direction."        * RELATED_TOPICS        o Health_&_Medicine        # Cancer # Brain_Tumor # Lung_Cancer # Skin_Cancer #        Colon_Cancer # Lymphoma # Prostate_Cancer # Leukemia        * RELATED_TERMS        o Human_genome o Meiosis o Turner_syndrome o Cancer o        Chemotherapy o Monoclonal_antibody_therapy o Prostate_cancer        o Brain_tumor              ==========================================================================               Print               Email               Share       ==========================================================================       ****** 1 ****** ***** 2 ***** **** 3 ****       *** 4 *** ** 5 ** Breaking this hour       ==========================================================================        * First_Snapshots_of_Fermion_Pairs *        Why_No_Kangaroos_in_Bali;_No_Tigers_in_Australia        * New_Route_for_Treating_Cancer:_Chromosomes *        Giant_Stone_Artefacts_Found:_Prehistoric_Tools        * Astonishing_Secrets_of_Tunicate_Origins *        Most_Distant_Active_Supermassive_Black_Hole *        Creative_People_Enjoy_Idle_Time_More_Than_Others        * Restoring_Fragile_X_Protein_Production *        Earth's_Solid_Metal_Sphere_Is_'Textured' *        Elephants_Vary_Their_Dinner_Menu_Day-To-Day              Trending Topics this week       ==========================================================================       HEALTH_&_MEDICINE Patient_Education_and_Counseling Birth_Defects       Cholesterol MIND_&_BRAIN Educational_Psychology Stroke Autism       LIVING_&_WELL Fitness Healthy_Aging Nutrition                     ==========================================================================              Strange & Offbeat       ==========================================================================       HEALTH_&_MEDICINE Holograms_for_Life:_Improving_IVF_Success       Grocery_Store_Carts_Set_to_Help_Diagnose_Common_Heart_Rhythm_Disorder_and       Prevent_Stroke DNA_Can_Fold_Into_Complex_Shapes_to_Execute_New_Functions       MIND_&_BRAIN AI_Tests_Into_Top_1%_for_Original_Creative_Thinking       Everyone's_Brain_Has_a_Pain_Fingerprint_--_New_Research_Has_Revealed_for_the       First_Time       Scientists_Discover_Spiral-Shaped_Signals_That_Organize_Brain_Activity       LIVING_&_WELL Illusions_Are_in_the_Eye,_Not_the_Mind       Amputees_Feel_Warmth_in_Their_Missing_Hand       Why_Do_Champagne_Bubbles_Rise_the_Way_They_Do?_Scientists'_New_Discovery_Is       Worthy_of_a_Toast Story Source: Materials provided by       Yale_University. Original written by Mallory Locklear.              Note: Content may be edited for style and length.                     ==========================================================================       Journal Reference:        1. Vishruth Girish et al. Oncogene-like addiction to aneuploidy        in human        cancers. Science, 2023 DOI: 10.1126/science.adg452       ==========================================================================              Link to news story:       https://www.sciencedaily.com/releases/2023/07/230706152349.htm              --- up 1 year, 18 weeks, 3 days, 10 hours, 50 minutes        * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)       SEEN-BY: 15/0 106/201 114/705 123/120 153/7715 218/700 226/30 227/114       SEEN-BY: 229/110 112 113 307 317 400 426 428 470 664 700 291/111 292/854       SEEN-BY: 298/25 305/3 317/3 320/219 396/45 5075/35       PATH: 317/3 229/426           |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca